Uncommon Eye Ailment Reveals Hidden Lung Cancer
"When an Iris Tumor Led to a Shocking Bronchial Carcinoma Diagnosis"
Uveal metastases, the most frequent type of intraocular tumors, often originate from lung cancer, with an incidence ranging from 2% to 6.7%. Metastases to the anterior uvea, specifically the iris and ciliary body, are rare, accounting for 7.2% to 14.1% of intraocular metastases. This case highlights the importance of thorough investigation when unusual symptoms arise.
A 45-year-old chronic smoker presented with decreased visual acuity (4/10). A slit-lamp examination revealed a clear cornea, fine retro-descemet precipitates, and an elevated intraocular pressure of 30 mmHg. A key finding was a neovascularized iris lesion with iridocorneal angle involvement, accompanied by a scleral mass in the superotemporal region. Fundus examination showed a clear vitreous, normal retina, and optic disc. UBM revealed an iris mass invading the angle, ciliary body, and adjacent sclera.
Initial diagnostic considerations included uveal metastasis and achromic iris melanoma. The patient was hospitalized for a comprehensive evaluation to identify a primary cancer. A CT scan of the chest revealed a right upper lobe pulmonary tumor with mediastinal lymph node involvement. Brain MRI showed lesions indicative of secondary spread, while abdominal CT did not reveal any abnormalities. Bronchoscopy with biopsy of the primary lesion confirmed the diagnosis of adenocarcinoma of the lung.
Early Recognition of Iris Metastasis
Metastatic disease remains the most common cause of intraocular tumors involving the uveal tract, although most metastases occur in the choroid. Only about 8% of intraocular metastases arise in the iris, and the 2018 report described lung adenocarcinoma first presenting through an iris lesion. Lung carcinoma is also identified as the second most common primary tumor causing iris metastases after breast carcinoma, with symptoms that may include pain, blurred vision, or light sensitivity.
Decoding the Link: How an Eye Exam Can Detect Lung Cancer
This case illustrates a rare presentation of lung cancer, where the initial symptoms manifested in the eye. The iris tumor and associated findings prompted a search for the primary source, eventually leading to the diagnosis of bronchial carcinoma. This highlights the importance of considering metastatic disease in patients presenting with unusual ocular findings, especially those with a history of smoking or other risk factors for cancer.
- Comprehensive Eye Exams: Regular eye exams can detect abnormalities not immediately apparent to the patient.
- Detailed History: Providing a complete medical history, including smoking habits and family history of cancer, is crucial.
- Imaging Techniques: Ultrasound Biomicroscopy (UBM) and other imaging techniques can visualize structures of the eye.
- Prompt Referral: Ophthalmologists play a crucial role in recognizing signs.
- Interdisciplinary Collaboration: Effective communication and collaboration between ophthalmologists, oncologists, and other specialists are essential for accurate diagnosis and treatment.
Recent Diagnostic Case Reports
Recent publications continue to characterize iris metastasis as a rare manifestation of lung cancer. A 2026 report described unilateral iris metastasis from already metastatic, EGFR-wild-type non-small cell lung cancer, while another 2026 case reported exceptionally rare disseminated iris metastases from small-cell lung cancer. The small-cell case involved a 70-year-old man referred for blurred vision and pain, and a separate report highlighted anterior chamber paracentesis as a potentially less invasive alternative to iris biopsy in carefully selected patients.
A Reminder to Keep Our Eyes Open
This unique case reinforces the importance of comprehensive eye exams and detailed medical histories in detecting underlying systemic diseases, particularly cancer. It highlights the critical role of ophthalmologists in recognizing subtle signs and collaborating with other specialists for timely diagnosis and treatment, ultimately improving patient outcomes.
Interpreting Iris Masses
An iris mass in a patient with lung carcinoma should not automatically be assumed to represent metastasis. A 2026 report notes that small-cell lung cancer constitutes about 15% of lung cancers and that an isolated iris lesion may or may not indicate disseminated disease. In a retrospective series of 104 iris-metastasis cases from systemic malignancies, breast cancer was the most frequent primary tumor at 33%, followed by lung cancer at 27% and cutaneous melanoma at 12%.
AI and Emerging Treatment Strategies
A 2026 review describes artificial intelligence and machine learning as increasingly important to how lung cancer is detected, classified, and treated. Its outlook emphasizes that survival is influenced by lifestyle habits, genetic makeup, and environmental conditions. WebMD's review of the treatment horizon also points readers toward emerging lung-cancer treatments and current clinical-trial trends.